clonazepam has been researched along with Benign Neoplasms, Brain in 9 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "At our Institute, during the last decade, the incidence of hepatic veno-occlusive disease (HVOD) appears to be on the increase among pediatric patients treated with BU-thiotepa (BU-TTP)-conditioning regimen." | 7.74 | Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. ( Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N, 2008) |
| " Acute seizures were treated with intranasal midazolam." | 3.83 | Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study. ( Heimans, JJ; Koekkoek, JA; Postma, TJ; Reijneveld, JC; Taphoorn, MJ, 2016) |
| " Pharmacological treatment with tetrabenazine, clonazepam and trihexiphenydile allowed a very limited improvement of dystonia; the course was complicated by dystonic storms and decompensations resulting from the iatrogenous panhypopituitarism." | 3.74 | [Severe generalized dystonia due to postradiotherapy cerebral calcifications]. ( Anheim, M; Chanson, JB; Fleury, M; Lagha-Boukbiza, O; Sellal, F; Tranchant, C, 2008) |
| "At our Institute, during the last decade, the incidence of hepatic veno-occlusive disease (HVOD) appears to be on the increase among pediatric patients treated with BU-thiotepa (BU-TTP)-conditioning regimen." | 3.74 | Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen. ( Amoroso, L; Benhamou, E; Cacchione, A; Couanet, DV; Hartmann, O; LeMaitre, A; Simonnard, N, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koekkoek, JA | 1 |
| Postma, TJ | 1 |
| Heimans, JJ | 1 |
| Reijneveld, JC | 1 |
| Taphoorn, MJ | 1 |
| Chanson, JB | 1 |
| Anheim, M | 1 |
| Lagha-Boukbiza, O | 1 |
| Fleury, M | 1 |
| Sellal, F | 1 |
| Tranchant, C | 1 |
| Cacchione, A | 1 |
| LeMaitre, A | 1 |
| Couanet, DV | 1 |
| Benhamou, E | 1 |
| Amoroso, L | 1 |
| Simonnard, N | 1 |
| Hartmann, O | 1 |
| Patejdl, R | 1 |
| Borchert, K | 1 |
| Pagumbke, H | 1 |
| Benecke, R | 1 |
| Grossmann, A | 1 |
| Prall, F | 1 |
| Kahl, C | 1 |
| Freund, M | 1 |
| Schmitt, M | 1 |
| Walter, U | 1 |
| Provini, F | 1 |
| Vetrugno, R | 1 |
| Pastorelli, F | 1 |
| Lombardi, C | 1 |
| Plazzi, G | 1 |
| Marliani, AF | 1 |
| Lugaresi, E | 1 |
| Montagna, P | 1 |
| Burke, L | 1 |
| Berenberg, RA | 1 |
| Kim, KS | 1 |
| Ikezaki, K | 2 |
| Nomura, T | 1 |
| Takahashi, M | 1 |
| Fritz-Zieroth, B | 1 |
| Inamura, T | 1 |
| Fukui, M | 1 |
| Szücs, A | 1 |
| Bódizs, R | 1 |
| Barsi, P | 1 |
| Halász, P | 1 |
| Black, KL | 1 |
| Toga, AW | 1 |
9 other studies available for clonazepam and Benign Neoplasms, Brain
| Article | Year |
|---|---|
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study.
Topics: Administration, Buccal; Administration, Intranasal; Aged; Brain Neoplasms; Clonazepam; Feasibility S | 2016 |
[Severe generalized dystonia due to postradiotherapy cerebral calcifications].
Topics: Anti-Dyskinesia Agents; Basal Ganglia; Brain Neoplasms; Calcinosis; Child; Clonazepam; Craniopharyng | 2008 |
Risk factors for hepatic veno-occlusive disease: a retrospective unicentric study in 116 children autografted after a high-dose BU-thiotepa regimen.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Busulfan; Carboplatin; Child; Child, Preschool; | 2008 |
Posterior reversible encephalopathy syndrome (PRES): an unusual primary manifestation of a diffuse large B-cell lymphoma.
Topics: Agraphia; Anticonvulsants; Antineoplastic Agents; Brain; Brain Neoplasms; Clonazepam; Handwriting; H | 2011 |
Status dissociatus after surgery for tegmental ponto-mesencephalic cavernoma: a state-dependent disorder of motor control during sleep.
Topics: Adult; Anticonvulsants; Brain Neoplasms; Clonazepam; Dissociative Disorders; Electroencephalography; | 2004 |
Choreoballismus: a nonhemorrhagic complication of venous angiomas.
Topics: Brain Neoplasms; Caudate Nucleus; Chorea; Clonazepam; Haloperidol; Hemangioma; Humans; Male; Middle | 1984 |
Selective and prolonged MRI enhancement by Mn-TPPS in an experimental rat brain tumour with peripheral benzodiazepine receptors.
Topics: Animals; Brain Neoplasms; Clonazepam; Contrast Media; Glioma; Isoquinolines; Kidney; Magnetic Resona | 1994 |
Insomnia and fronto-basal tumor: a case report.
Topics: Brain Neoplasms; Clonazepam; Frontal Lobe; GABA Modulators; Glioma; Humans; Male; Middle Aged; Sleep | 2001 |
Imaging of brain tumors using peripheral benzodiazepine receptor ligands.
Topics: Animals; Autoradiography; Brain Neoplasms; Clonazepam; Female; Flunitrazepam; Glioma; Image Processi | 1989 |